Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Arrowhead Provides Update on IND for ARC-520 Phase 2b Study

Business Wire January 12, 2015

Loxo Oncology Appoints Alan Fuhrman to Board of Directors

GlobeNewswire January 12, 2015

Loxo Oncology Appoints Alan Fuhrman to Board of Directors

GlobeNewswire January 12, 2015

AVEO to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Business Wire January 12, 2015

Q&A: Actinium Pharmaceuticals Inc. CEO Eyes Orphan Drug Application for Flagship Drug

Accesswire January 12, 2015

Sernova to Participate in Biotech Showcase(TM) 2015 Healthcare Conference in San Francisco

Marketwired January 12, 2015

The Pancreatic Cancer Action Network And The National Cancer Institute's Frederick National Laboratory For Cancer Research Join Forces For Research Initiative

PR Newswire January 12, 2015

BioLife Solutions Reports Preliminary Revenue for 2014

PR Newswire January 12, 2015

- Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors -

Business Wire January 12, 2015

Pluristem Issues Letter to Shareholders

GlobeNewswire January 12, 2015

ORYZON Appoints Greg Weaver as Global Chief Financial Officer

PR Newswire January 12, 2015

ICL Launches "Potash for Growth" Program in Ethiopia

Canada NewsWire January 12, 2015

ERYTECH Announces ADR Level 1 Listing in the US

Business Wire January 12, 2015

QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies

PR Newswire January 12, 2015

SHIRE PLC - Shire to Acquire NPS Pharma

PR Newswire January 12, 2015

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases

PR Newswire January 12, 2015

Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

Business Wire January 12, 2015

Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company

GlobeNewswire January 11, 2015

CheckMate -017, A Phase 3 Study of Opdivo (Nivolumab) Compared to Docetaxel in Patients with Second-Line Squamous Cell Non-small Cell Lung Cancer, Stopped Early

Business Wire January 11, 2015

Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New Medicines for the Treatment of People with Cystic Fibrosis

Business Wire January 11, 2015